Clinical Trials
3 trialsNCT04037462 2024-06-14
Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy
VA Office of Research and Development
Phase 1/2 Terminated
NCT00953849 2017-03-07
Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity
VA Office of Research and Development
Phase 1/2 Completed
NCT01324102 2016-01-01
YogaCares
VA Office of Research and Development
Phase 1/2 Completed